Trioda

Lamivudine belongs to a class of drugs called nucleoside reverse transcriptase inhibitors.

It reduces the number of viruses (HIV and hepatitis) in the blood. It also increases the number of infection-fighting cells (CD4 cells) in the body.

Tenofovir is an antiviral drug that belongs to the nucleoside reverse transcriptase inhibitors (NRTIs). Efavirenz belongs to a class of antiretroviral drugs called non-nucleoside reverse transcriptase inhibitors (NNRTIs).

It inhibits HIV replication, thereby reducing the amount of virus in the blood. Lamivudine is part of a combination antiretroviral therapy used to treat infections caused by human immunodeficiency virus (HIV).

Tenofovir is used in combination with other antiviral drugs to treat human immunodeficiency virus (HIV) infection. Efavirenz is used in combination with other medicines to treat human immunodeficiency virus (HIV) infection.